PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference
PacBio (NASDAQ: PACB), a leading developer of high-quality sequencing solutions, has announced its participation in the 43rd Annual J.P. Morgan Healthcare Conference. The presentation is scheduled for Tuesday, January 14, 2025, at 4:30 PM PT (7:30 PM ET) in San Francisco, California.
Interested parties can access a live webcast of the event through PacBio's investors page at investor.pacificbiosciences.com. The presentation recording will remain available for a minimum of 30 days after the event.
PacBio (NASDAQ: PACB), un importante sviluppatore di soluzioni di sequenziamento di alta qualità, ha annunciato la sua partecipazione al 43º Annual J.P. Morgan Healthcare Conference. La presentazione è programmata per martedì 14 gennaio 2025, alle 16:30 PT (19:30 ET) a San Francisco, California.
Le parti interessate possono accedere a un webcast dal vivo dell'evento tramite la pagina degli investitori di PacBio su investor.pacificbiosciences.com. La registrazione della presentazione rimarrà disponibile per un minimo di 30 giorni dopo l'evento.
PacBio (NASDAQ: PACB), un importante desarrollador de soluciones de secuenciación de alta calidad, ha anunciado su participación en la 43ª Conferencia Anual de Atención Médica de J.P. Morgan. La presentación está programada para el martes 14 de enero de 2025, a las 4:30 PM PT (7:30 PM ET) en San Francisco, California.
Las partes interesadas pueden acceder a un webcast en vivo del evento a través de la página de inversores de PacBio en investor.pacificbiosciences.com. La grabación de la presentación estará disponible por un mínimo de 30 días después del evento.
PacBio (NASDAQ: PACB), 고품질 시퀀싱 솔루션의 주요 개발업체는 제43회 J.P. Morgan 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 발표는 2025년 1월 14일 화요일, 태평양 표준시 기준 오후 4:30(동부 표준시 기준 오후 7:30)에 샌프란시스코, 캘리포니아에서 예정되어 있습니다.
관심 있는 분들은 PacBio의 투자자 페이지인 investor.pacificbiosciences.com을 통해 이벤트의 실시간 웹캐스트에 접근할 수 있습니다. 발표 녹화는 이벤트 이후 최소 30일 동안 이용할 수 있습니다.
PacBio (NASDAQ: PACB), un développeur de solutions de séquençage de haute qualité, a annoncé sa participation à la 43e Conférence Annuelle sur la Santé de J.P. Morgan. La présentation est prévue pour le mardi 14 janvier 2025, à 16h30 PT (19h30 ET) à San Francisco, Californie.
Les parties intéressées peuvent accéder à un webcast en direct de l'événement via la page des investisseurs de PacBio à investor.pacificbiosciences.com. L'enregistrement de la présentation restera disponible pendant un minimum de 30 jours après l'événement.
PacBio (NASDAQ: PACB), ein führender Entwickler von hochwertigen Sequenzierungslösungen, hat seine Teilnahme an der 43. J.P. Morgan Healthcare Conference bekannt gegeben. Die Präsentation ist für Dienstag, den 14. Januar 2025, um 16:30 Uhr PT (19:30 Uhr ET) in San Francisco, Kalifornien, angesetzt.
Interessierte Parteien können über die Investoren-Seite von PacBio unter investor.pacificbiosciences.com auf einen Live-Webcast der Veranstaltung zugreifen. Die Aufzeichnung der Präsentation bleibt mindestens 30 Tage nach der Veranstaltung verfügbar.
- None.
- None.
MENLO PARK, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14, 2025, at 4:30 PM PT (7:30 PM ET) in San Francisco, California.
A live webcast of the event can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the event.
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies stem from two highly differentiated core technologies focused on accuracy, quality, and completeness, which include our HiFi long-read sequencing and our SBB® short-read sequencing technologies. Our products address solutions across a broad set of research applications, including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
Todd Friedman
ir@pacb.com
Media:
pr@pacb.com
FAQ
When is PacBio (PACB) presenting at the 2025 J.P. Morgan Healthcare Conference?
How can investors watch PacBio's (PACB) J.P. Morgan Healthcare Conference presentation?
How long will PacBio's (PACB) 2025 J.P. Morgan presentation replay be available?
Which healthcare conference is PacBio (PACB) participating in January 2025?
